155
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Examining the Suitability of Riboflavin/UVA Treatment for Strengthening the Stromal Bioequivalent of a Human Cornea Construct

&
Pages 217-231 | Received 30 Apr 2010, Accepted 25 Oct 2010, Published online: 28 Jan 2011

REFERENCES

  • Hornof M, Toropainen E, Urtti A. Cell culture models of the ocular barriers. Eur J Pharm Biopharm. 2005;60:207–225.
  • Minami Y, Sugihara H, Oono S. Reconstruction of cornea in three-dimensional collagen gel matrix culture. Invest Ophthalmol Vis Sci. 1993;34:2316–2324.
  • Tegtmeyer S, Reichl S, Müller-Goymann CC. Cultivation and characterization of a bovine in vitro model of the cornea. Pharmazie. 2004;59:464–471.
  • Reichl S, Müller-Goymann CC. The use of a porcine organotypic cornea construct for permeation studies from formulations containing befunolol hydrochloride. Int J Pharm. 2003;250:191–201.
  • Schneider AI, Maier-Reif K, Graeve T. Constructing an in vitro cornea from cultures of the three specific corneal cell types. In Vitro Cell Dev Biol Anim. 1999;35:515–526.
  • Zieske JD, Mason VS, Wasson ME, et al. Basement membrane assembly and differentiation of cultured corneal cells: Importance of culture environment and endothelial cell interaction. Exp Cell Res. 1994;214:621–633.
  • Germain L, Carrier P, Auger FA, et al. Reconstructed human cornea produced in vitro by tissue engineering. Pathobiology. 1999;67:140–147.
  • Griffith M, Osborne R, Munger R, et al. Functional human corneal equivalents constructed from cell lines. Science. 1999;286:2169–2172.
  • Reichl S, Döhring S, Bednarz J, et al. Human cornea construct HCC—An alternative for in vitro permeation studies? A comparison with human donor corneas. Eur J Pharm Biopharm. 2005;60:305–308.
  • Reichl S, Bednarz J, Müller-Goymann CC. Human corneal equivalent as cell culture model for in vitro drug permeation studies. Br J Ophthalmol. 2004;88:560–565.
  • Zorn-Kruppa M, Tykhonova S, Belge G, et al. A human corneal equivalent constructed from SV40-immortalised corneal cell lines. Altern Lab Anim. 2005;32:37–45.
  • Germain L, Carrier P, Auger FA, et al. Can we produce a human corneal equivalent by tissue engineering? Pro Retin Eye Res. 2000;19:497–527.
  • Reichl S. Cell culture models of the human cornea—A comparative evaluation of their usefulness to determine ocular drug absorption in vitro. J Pharm Pharmacol. 2008;60:299–307.
  • Griffith M, Hakim M, Shimmura S, et al. Artificial human corneas: Scaffolds for transplantation and host regeneration. Cornea. 2002;21:S54–S61.
  • Griffith M, Jackson WB, Lagali N, et al. Artificial corneas: A regenerative medicine approach. Eye. 2009;23:1985–1989.
  • Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-A-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135:620–627.
  • Spörl E, Huhle M, Kasper M, et al. Erhöhung der Festigkeit der Hornhaut durch Vernetzung. Ophthalmologe. 1997;94:902–906.
  • Wollensak G, Spoerl E, Seiler T. Stress-strain measurements of human and porcine corneas after riboflavin-ultraviolet-A-induced cross-linking. J Cataract Refract Surg. 2003;29:1780–1785.
  • Spörl E, Raiskup-Wolf F, Pillunat LE. Biophysical principles of collagen cross-linking. Klin Monatsbl Augenheilkd. 2008;225:131–137.
  • Bell E, Ehrlich HP, Buttle DJ, et al. Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. Science. 1981;211:1052–1054.
  • Manzer AK, Lombardi-Borgia S, Schäfer-Korting M, et al. SV40-transformed human corneal keratocytes: Optimisation of serum-free culture conditions. ALTEX. 2009;26:33–39.
  • Mezger TG. The Rheology Handbook: For Users of Rotational and Oscillatory Rheometers. 2nd ed. Hannover, Germany: Vincentz Network, 2006; pp. 114–170.
  • Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254.
  • Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–685.
  • Ethier CR, Johnson M, Ruberti J. Ocular biomechanics and biotransport. Annu Rev Biomed Eng. 2004;6:249–273.
  • Ruberti JW, Zieske JD. Prelude to corneal tissue engineering—Gaining control of collagen organization. Prog Retin Eye Res. 2008;27:549–577.
  • Maurice DM. The structure and transparency of the cornea. J Physiol. 1957;136:263–286.
  • Li F, Griffith M, Li Z, et al. Recruitment of multiple cell lines by collagen-synthetic copolymer matrices in corneal regeneration. Biomaterials. 2005;26:3093–3104.
  • Spörl E, Schreiber J, Hellmund K, et al. Cross-linking effects in the cornea of rabbits. Ophthalmologe. 2000;97:203–206.
  • Wollensak G, Redl B. Gel electrophoretic analysis of corneal collagen after photodynamic cross-linking treatment. Cornea. 2008;27:353–356.
  • Wollensak G, Spörl E, Reber F, et al. Corneal endothelial cytotoxicity of riboflavin/UVA treatment in vitro. Ophthalmic Res. 2003;35:324–328.
  • Wollensak G, Spoerl E, Reber F, et al. Keratocyte cytotoxicity of riboflavin/UVA treatment in vitro. Eye. 2004;18:718–722.
  • Wollensak G, Spoerl E, Wilsch M, et al. Endothelial cell damage after riboflavin-ultraviolet—A treatment in the rabbit. J Cataract Refract Surg. 2003;29:1786–1790.
  • Wollensak G, Spoerl E, Wilsch M, et al. Keratocyte apoptosis after corneal collagen cross-linking using riboflavin/UVA treatment. Cornea. 2004;23:43–49.
  • Spoerl E, Mrochen M, Sliney D, et al. Safety of UVA-riboflavin cross-linking of the cornea. Cornea. 2007;26:385–389.
  • Cho KS, Lee EH, Choi JS, et al. Reactive oxygen species-induced apoptosis and necrosis in bovine corneal endothelial cells. Invest Ophthalmol Vis Sci. 1999;40:911–919.
  • Wang F. UVA/riboflavin-induced apoptosis in mouse cornea. Ophthalmologica. 2008;222:369–372.
  • Collins JA, Schandl CA, Young KK, et al. Major DNA fragmentation is a late event in apoptosis. J Histochem Cytochem. 1997;45:923–934.
  • Darzynkiewicz Z, Juan G, Li X, et al. Cytometry in cell necrobiology: Analysis of apoptosis and accidental cell death (necrosis). Cytometry. 1997;27:1–20.
  • O’Brien MC, Healy SF, Raney SR, et al. Discrimination of late apoptotic/necrotic cells (type III) by flow cytometry in solid tumors. Cytometry. 1997;28:81–89.
  • Leist M, Nicotera P. The shape of cell death. Biochem Biophys Res Commun. 1997;236:1–9.
  • Bertrand R, Solary E, O’Connor P, et al. Induction of a common pathway of apoptosis by staurosporine. Exp Cell Res. 1994;211:314–321.
  • Härtel S, Zorn-Kruppa M, Tykhonova S, et al. Staurosporine-induced apoptosis in human cornea epithelial cells in vitro. Cytometry Part A. 2003;55A:15–23.
  • Thuret G, Chiquet C, Herrag S, et al. Mechanisms of staurosporine-induced apoptosis in a human corneal endothelial cell line. Br J Ophthalmol. 2003;87:346–352.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.